Roopa Industries Ltd is in the business of TPP and its allied productsBusiness Overview: RIL manufactures Bulk Drugs, Drug Intermediates, Nutraceuticals, and fine chemicals. It produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into production of Cephalosporins, Statins etc.,) and Nutraceuticals such...
Submission of newspaper clippings with regard to 41st Annual General Meeting and e-voting
In compliance with Regulation 34 of the SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015, we are forwarding herewith Annual Report for the Financial Year 2025-26 ....
The 41st Annual General Meeting of the Company is scheduled to be held on 30th September 2026 at 10.00 a.m. through Video Conference (VC) or Other Audio Visual Means (OAVM)
ROOPA INDUSTRIES LIMITED's Board of Directors has approved the notice for its 41st Annual General Meeting (AGM). The AGM is scheduled for September 30 and will be held virtually via video conferencing. Shareholders eligible to vote will be those on record as of the cut-off date, September 18. Remote e-voting...
Roopa Industries announced its financial results for the quarter ended 30 June 2026. Total income from operations was ₹3.33 Cr. The company reported a net profit of ₹0.33 Cr for the period, with earnings per share (basic and diluted) at ₹0.43. These unaudited results were reviewed by the Audit Committee...
